Charleston, SC, United States of America

Daniel Fernandes

This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Musc Foundation for Research Development. Active years: 2016-2022.

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Charleston, SC (US) (2016 - 2019)
  • Awendaw, SC (US) (2022)

Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel Fernandes

Introduction

Daniel Fernandes is a notable inventor based in Charleston, SC (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for medical applications. With a total of 3 patents to his name, Fernandes continues to push the boundaries of scientific research.

Latest Patents

Among his latest patents, Fernandes has developed anti-nucleolin antibodies. This patent provides methods for producing these antibodies and describes their use in treating both malignant and non-malignant diseases. Another significant invention is related to nucleolin antibodies, which includes methods for producing human monoclonal antibodies to human nucleolin. This invention also outlines the use of these antibodies in diagnosing and treating diseases where nucleolin expression plays a critical role.

Career Highlights

Daniel Fernandes is currently associated with the MUSC Foundation for Research Development. His work at this institution has allowed him to focus on innovative research that has the potential to impact medical treatments significantly.

Collaborations

Throughout his career, Fernandes has collaborated with talented individuals such as Natalie Sutkowski and Brian Hoel. These collaborations have fostered a productive environment for research and innovation.

Conclusion

Daniel Fernandes exemplifies the spirit of innovation in the field of biotechnology. His contributions through patents and collaborative efforts continue to advance medical science and improve treatment options for various diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…